CCP
Clough Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-57,200
| Closed | -$2.25M | – | 113 |
|
|
2024
Q4 | $2.25M | Buy |
+57,200
| New | +$2.25M | 0.26% | 64 |
|
|
2024
Q3 | – | Sell |
-20,939
| Closed | -$1.13M | – | 136 |
|
|
2024
Q2 | $1.13M | Buy |
+20,939
| New | +$1.13M | 0.12% | 79 |
|
|
2024
Q1 | – | Sell |
-5,226
| Closed | -$327K | – | 133 |
|
|
2023
Q4 | $327K | Buy |
+5,226
| New | +$327K | 0.04% | 168 |
|
|
2023
Q3 | – | Sell |
-56,969
| Closed | -$3.2M | – | 215 |
|
|
2023
Q2 | $3.2M | Sell |
56,969
-65,131
| -53% | -$3.66M | 0.32% | 89 |
|
|
2023
Q1 | $5.52M | Sell |
122,100
-139,600
| -53% | -$6.31M | 0.6% | 62 |
|
|
2022
Q4 | $10.6M | Sell |
261,700
-153,067
| -37% | -$6.22M | 1.08% | 33 |
|
|
2022
Q3 | $27.1M | Buy |
414,767
+97,500
| +31% | +$6.37M | 2.89% | 7 |
|
|
2022
Q2 | $19.3M | Buy |
317,267
+111,160
| +54% | +$6.76M | 2.39% | 16 |
|
|
2022
Q1 | $12.9M | Buy |
206,107
+100,100
| +94% | +$6.28M | 0.98% | 41 |
|
|
2021
Q4 | $8.03M | Sell |
106,007
-35,300
| -25% | -$2.67M | 0.54% | 56 |
|
|
2021
Q3 | $15.8M | Sell |
141,307
-31,860
| -18% | -$3.57M | 0.96% | 42 |
|
|
2021
Q2 | $28M | Sell |
173,167
-13,810
| -7% | -$2.24M | 1.52% | 17 |
|
|
2021
Q1 | $22.8M | Buy |
186,977
+41,970
| +29% | +$5.11M | 1.02% | 30 |
|
|
2020
Q4 | $22.2M | Sell |
145,007
-121,820
| -46% | -$18.7M | 1.58% | 22 |
|
|
2020
Q3 | $22.3M | Sell |
266,827
-30,200
| -10% | -$2.53M | 1.61% | 18 |
|
|
2020
Q2 | $21.8M | Hold |
297,027
| – | – | 2.14% | 9 |
|
|
2020
Q1 | $12.6M | Sell |
297,027
-147,900
| -33% | -$6.27M | 1.25% | 26 |
|
|
2019
Q4 | $27.1M | Sell |
444,927
-34,876
| -7% | -$2.12M | 2.31% | 14 |
|
|
2019
Q3 | $19.7M | Buy |
479,803
+38,500
| +9% | +$1.58M | 1.63% | 17 |
|
|
2019
Q2 | $20.8M | Sell |
441,303
-138,963
| -24% | -$6.55M | 2.04% | 11 |
|
|
2019
Q1 | $20.7M | Buy |
580,266
+64,200
| +12% | +$2.29M | 1.81% | 18 |
|
|
2018
Q4 | $14.7M | Buy |
516,066
+178,335
| +53% | +$5.1M | 1.73% | 14 |
|
|
2018
Q3 | $15M | Sell |
337,731
-45,100
| -12% | -$2M | 1.41% | 21 |
|
|
2018
Q2 | $22.5M | Sell |
382,831
-177,400
| -32% | -$10.4M | 2.01% | 15 |
|
|
2018
Q1 | $25.6M | Sell |
560,231
-330,400
| -37% | -$15.1M | 2.45% | 10 |
|
|
2017
Q4 | $20.9M | Buy |
890,631
+110,700
| +14% | +$2.6M | 1.74% | 19 |
|
|
2017
Q3 | $13.9M | Sell |
779,931
-17,300
| -2% | -$309K | 0.93% | 35 |
|
|
2017
Q2 | $12.8M | Sell |
797,231
-27,633
| -3% | -$443K | 0.89% | 37 |
|
|
2017
Q1 | $17.9M | Sell |
824,864
-13,927
| -2% | -$303K | 1.14% | 27 |
|
|
2016
Q4 | $16.7M | Buy |
+838,791
| New | +$16.7M | 1.11% | 32 |
|